亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Diagnosis and Complication Risk Assessment of Pancreatic Diabetes within Normal Value Ranges of Leuc

总结
This patent can use for daily complication risk Assessment of all diabetic patients and save lifes, suffering from the diabetic complications at all around the world. it is more important method than Hemoglobin A1c. Because all diabetic complications can monitorizing using one marker (procalcitonin) in 24 hours period. New technology of insulin pump system or traditional diabetes mellitus therapy need this invention for proper diabetic complication (retinopathy, nephropathy,neuropathy) treatment
详细技术说明
This method use rapid or Automatic test device for procalcitonin blood levels
合作类型
License agreement
附加资料
Inventor: Chonge Chen | Cleph. Sturt. Keklam | chuxian Wu
Priority Number: CN100572554C
IPC Current: C12Q000168
Assignee Applicant: The Chinese University of Hong Kong
Title: Risk estimution for diabetic to suffer from diabetic renopathy or blood-lipid imbalance | Evaluation diabetes patients suffer from diabetic nephropathy, or dyslipidemia disorder risk of
Usefulness: Risk estimution for diabetic to suffer from diabetic renopathy or blood-lipid imbalance | Evaluation diabetes patients suffer from diabetic nephropathy, or dyslipidemia disorder risk of
Novelty: Risk estimation for diabetic to suffer from diabetic renopathy or blood-lipid imbalance
主要类别
诊断/治疗
细分类别
其他疾病
申请号码
EP20120154587
覆盖范围
EPO designated contracting states
专利信息
Status: Patent Application
其他
Price: negotiable
国家/地区
土耳其

欲了解更多信息,请点击 这里
移动设备